Wilson Sonsini partner Andrea Linna was quoted in a Wall Street Journal article titled “Counsel Health Grabs $25 Million for AI-Augmented Healthcare Service,” offering insight on federal regulatory oversight of AI in healthcare. Andrea explained that whether such systems fall under U.S. Food and Drug Administration regulation generally depends on “the intended use of the AI, whether a provider is in the loop and if the provider can make independent, informed clinical decisions and independently review the basis for the AI’s recommendations.”

Click here to read the full article (subscription required).